0000899243-20-013089.txt : 20200514
0000899243-20-013089.hdr.sgml : 20200514
20200514163106
ACCESSION NUMBER: 0000899243-20-013089
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200512
FILED AS OF DATE: 20200514
DATE AS OF CHANGE: 20200514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: aMoon 2 Fund Limited Partnership
CENTRAL INDEX KEY: 0001744099
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39279
FILM NUMBER: 20878280
BUSINESS ADDRESS:
STREET 1: 34 YERUSHALAYIM RD.
CITY: RAANANA
STATE: L3
ZIP: 4350110
BUSINESS PHONE: 972(73)3989560
MAIL ADDRESS:
STREET 1: 34 YERUSHALAYIM RD.
CITY: RAANANA
STATE: L3
ZIP: 4350110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001797336
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823578375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: (857) 444-0553
MAIL ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-12
0
0001797336
Ayala Pharmaceuticals, Inc.
AYLA
0001744099
aMoon 2 Fund Limited Partnership
34 YERUSHALAIM RD.
BEIT GAMLA, 6TH FLOOR
RA'ANANA
L3
4350110
ISRAEL
0
0
1
0
Common Stock
2020-05-12
4
C
0
369231
0.00
A
1682549
D
Common Stock
2020-05-12
4
C
0
508924
0.00
A
2191473
D
Common Stock
2020-05-12
4
P
0
800000
15.00
A
2991473
D
Series A Preferred Stock
2020-05-12
4
C
0
738462
D
Common Stock
369231
0
D
Series B Preferred Stock
2020-05-12
4
C
0
1017848
D
Common Stock
508924
0
D
Each share of preferred stock was automatically converted into 0.5 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date.
/s/ Matthew Rudolph, Adv., Attorney-in-Fact for Yair Schindel
2020-05-14